ArticleCurrent therapeutic research, clinical and experimental2026

Treatment satisfaction and patient preference for efanesoctocog alfa over previous hemophilia A treatment: Results from the XTEND-1 phase 3 clinical trial.

Emil Spasov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.